<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />




<title>Daily Media Digest</title>

<script src="rmdlib/header-attrs-2.30/header-attrs.js"></script>
<script src="rmdlib/jquery-3.6.0/jquery-3.6.0.min.js"></script>
<meta name="viewport" content="width=device-width, initial-scale=1" />
<link href="rmdlib/bootstrap-3.3.5/css/flatly.min.css" rel="stylesheet" />
<script src="rmdlib/bootstrap-3.3.5/js/bootstrap.min.js"></script>
<script src="rmdlib/bootstrap-3.3.5/shim/html5shiv.min.js"></script>
<script src="rmdlib/bootstrap-3.3.5/shim/respond.min.js"></script>
<style>h1 {font-size: 34px;}
       h1.title {font-size: 38px;}
       h2 {font-size: 30px;}
       h3 {font-size: 24px;}
       h4 {font-size: 18px;}
       h5 {font-size: 16px;}
       h6 {font-size: 12px;}
       code {color: inherit; background-color: rgba(0, 0, 0, 0.04);}
       pre:not([class]) { background-color: white }</style>
<script src="rmdlib/navigation-1.1/tabsets.js"></script>
<script src="rmdlib/accessible-code-block-0.0.1/empty-anchor.js"></script>
<link href="rmdlib/font-awesome-6.4.0/css/all.min.css" rel="stylesheet" />
<link href="rmdlib/font-awesome-6.4.0/css/v4-shims.min.css" rel="stylesheet" />
<meta name="description" content="StockViz Dashboard Predicton Markets - Kalshi and Polymarket" />
<meta property="og:image" content="https://avatars3.githubusercontent.com/u/21966469?s=400&v=4" />

<style type="text/css">
  code{white-space: pre-wrap;}
  span.smallcaps{font-variant: small-caps;}
  span.underline{text-decoration: underline;}
  div.column{display: inline-block; vertical-align: top; width: 50%;}
  div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
  ul.task-list{list-style: none;}
    </style>










<style type = "text/css">
.main-container {
  max-width: 940px;
  margin-left: auto;
  margin-right: auto;
}
img {
  max-width:100%;
}
.tabbed-pane {
  padding-top: 12px;
}
.html-widget {
  margin-bottom: 20px;
}
button.code-folding-btn:focus {
  outline: none;
}
summary {
  display: list-item;
}
details > summary > p:only-child {
  display: inline;
}
pre code {
  padding: 0;
}
</style>


<style type="text/css">
.dropdown-submenu {
  position: relative;
}
.dropdown-submenu>.dropdown-menu {
  top: 0;
  left: 100%;
  margin-top: -6px;
  margin-left: -1px;
  border-radius: 0 6px 6px 6px;
}
.dropdown-submenu:hover>.dropdown-menu {
  display: block;
}
.dropdown-submenu>a:after {
  display: block;
  content: " ";
  float: right;
  width: 0;
  height: 0;
  border-color: transparent;
  border-style: solid;
  border-width: 5px 0 5px 5px;
  border-left-color: #cccccc;
  margin-top: 5px;
  margin-right: -10px;
}
.dropdown-submenu:hover>a:after {
  border-left-color: #adb5bd;
}
.dropdown-submenu.pull-left {
  float: none;
}
.dropdown-submenu.pull-left>.dropdown-menu {
  left: -100%;
  margin-left: 10px;
  border-radius: 6px 0 6px 6px;
}
</style>

<script type="text/javascript">
// manage active state of menu based on current page
$(document).ready(function () {
  // active menu anchor
  href = window.location.pathname
  href = href.substr(href.lastIndexOf('/') + 1)
  if (href === "")
    href = "index.html";
  var menuAnchor = $('a[href="' + href + '"]');

  // mark the anchor link active (and if it's in a dropdown, also mark that active)
  var dropdown = menuAnchor.closest('li.dropdown');
  if (window.bootstrap) { // Bootstrap 4+
    menuAnchor.addClass('active');
    dropdown.find('> .dropdown-toggle').addClass('active');
  } else { // Bootstrap 3
    menuAnchor.parent().addClass('active');
    dropdown.addClass('active');
  }

  // Navbar adjustments
  var navHeight = $(".navbar").first().height() + 15;
  var style = document.createElement('style');
  var pt = "padding-top: " + navHeight + "px; ";
  var mt = "margin-top: -" + navHeight + "px; ";
  var css = "";
  // offset scroll position for anchor links (for fixed navbar)
  for (var i = 1; i <= 6; i++) {
    css += ".section h" + i + "{ " + pt + mt + "}\n";
  }
  style.innerHTML = "body {" + pt + "padding-bottom: 40px; }\n" + css;
  document.head.appendChild(style);
});
</script>

<!-- tabsets -->

<style type="text/css">
.tabset-dropdown > .nav-tabs {
  display: inline-table;
  max-height: 500px;
  min-height: 44px;
  overflow-y: auto;
  border: 1px solid #ddd;
  border-radius: 4px;
}

.tabset-dropdown > .nav-tabs > li.active:before, .tabset-dropdown > .nav-tabs.nav-tabs-open:before {
  content: "\e259";
  font-family: 'Glyphicons Halflings';
  display: inline-block;
  padding: 10px;
  border-right: 1px solid #ddd;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li.active:before {
  content: "\e258";
  font-family: 'Glyphicons Halflings';
  border: none;
}

.tabset-dropdown > .nav-tabs > li.active {
  display: block;
}

.tabset-dropdown > .nav-tabs > li > a,
.tabset-dropdown > .nav-tabs > li > a:focus,
.tabset-dropdown > .nav-tabs > li > a:hover {
  border: none;
  display: inline-block;
  border-radius: 4px;
  background-color: transparent;
}

.tabset-dropdown > .nav-tabs.nav-tabs-open > li {
  display: block;
  float: none;
}

.tabset-dropdown > .nav-tabs > li {
  display: none;
}
</style>

<!-- code folding -->




</head>

<body>


<div class="container-fluid main-container">




<div class="navbar navbar-inverse  navbar-fixed-top" role="navigation">
  <div class="container">
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse" data-bs-toggle="collapse" data-target="#navbar" data-bs-target="#navbar">
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <a class="navbar-brand" href="index.html">StockViz</a>
    </div>
    <div id="navbar" class="navbar-collapse collapse">
      <ul class="nav navbar-nav">
        <li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-globe"></span>
     
    Macro
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports01/macro/rp-bnd.html">Fixed Income</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/macro/rp-cur.html">Currencies</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/macro/rp-cmdy.html">Commodities</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-arrows-v"></span>
     
    52w H&amp;L
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports01/eq/52wk-IN.html">India</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/eq/52wk-US.html">US</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-rocket"></span>
     
    ATH
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports01/eq/ath-IN.html">India</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/eq/ath-US.html">US</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-magnet"></span>
     
    Drawdowns
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports01/eq/drawdowns-IN.html">India</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/eq/drawdowns-US.html">US</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-train"></span>
     
    Streaks
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports01/eq/streaks-IN.html">India</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/eq/streaks-US.html">US</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-hand-pointer-o"></span>
     
    Indian Indices
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-risk.html">Performance Metrics</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-IN.html">Index Changes</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-MKT-CAP.html">Classification Changes</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-industry.html">Industry Metrics</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-syn.html">Synthetic Indices</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-vol-NIFTY.html">NIFTY Volatility</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/index/rp-valuations.html">Valuations</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports01/eq/results-IN.html">Result Dates</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports02/eq-in/rp-margin.html">Margin Report</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-shopping-bag"></span>
     
    Funds
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports03/mf/rp-IN.html">Indian Mutual Funds</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports03/pms/rp-IN.html">Indian PMS</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports02/etf-us/rp-risk.html">US ETFs</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports02/etf-us/rp-sector.html">US Sector ETFs</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports02/etf-us/rp-country.html">Country $ ETFs</a>
    </li>
  </ul>
</li>
<li class="dropdown">
  <a href="#" class="dropdown-toggle" data-toggle="dropdown" role="button" data-bs-toggle="dropdown" aria-expanded="false">
    <span class="fa fa-percent"></span>
     
    Fama-French
     
    <span class="caret"></span>
  </a>
  <ul class="dropdown-menu" role="menu">
    <li>
      <a href="https://stockviz.github.io/reports02/etf-us/rp-fama-french-industry.html">Industry</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports02/etf-us/rp-fama-french-factors.html">Factors</a>
    </li>
    <li>
      <a href="https://stockviz.github.io/reports02/etf-us/rp-fama-french-regression.html">Regressions</a>
    </li>
  </ul>
</li>
      </ul>
      <ul class="nav navbar-nav navbar-right">
        <li>
  <a href="https://stockviz.biz">
    <span class="fa fa-home"></span>
     
  </a>
</li>
<li>
  <a href="https://stockviz.substack.com">
    <span class="fa fa-envelope-o"></span>
     
  </a>
</li>
      </ul>
    </div><!--/.nav-collapse -->
  </div><!--/.container -->
</div><!--/.navbar -->

<div id="header">



<h1 class="title toc-ignore">Daily Media Digest</h1>
<h3 class="subtitle">2026-02-11</h3>

</div>

<div id="TOC">
<ul>
<li><a href="#apollo-hospitals-md-predicts-longterm-boom-in-indian-healthcare">Apollo Hospitals MD Predicts Long‑Term Boom in Indian Healthcare</a></li>
<li><a href="#healthcare-sector-outlook-growth-drivers-strategic-plans-and-impact-of-indiauseu-ftas">Healthcare Sector Outlook: Growth Drivers, Strategic Plans, and Impact of India‑US/EU FTAs</a></li>
<li><a href="#eu-us-trade-deals-government-consumption-push-boost-fii-prospects-nuvamas-shiv-deewan-highlights-opportunities-and-risks-at-nuvama-india-conference">EU &amp; US Trade Deals, Government Consumption Push Boost FII Prospects, Nuvama’s Shiv Deewan Highlights Opportunities and Risks at Nuvama India Conference</a></li>
<li><a href="#market-recap-management-insights-auto-fmcg-metals-and-regulatory-outlook">Market Recap &amp; Management Insights – Auto, FMCG, Metals, and Regulatory Outlook</a></li>
<li><a href="#ganesha-ecospheres-outlook-regulatory-hurdles-capacity-utilization-and-fy27-growth-prospects">Ganesha Ecosphere’s Outlook: Regulatory Hurdles, Capacity Utilization, and FY27 Growth Prospects</a></li>
<li><a href="#britannia-q3-earnings-highlight-revenue-and-margin-growth">Britannia Q3 Earnings Highlight Revenue and Margin Growth</a></li>
<li><a href="#indiqube-spaces-outlook-strong-q3-performance-and-aggressive-expansion-in-indias-micromarkets">IndiQube Spaces Outlook: Strong Q3 Performance and Aggressive Expansion in India’s Micro‑Markets</a></li>
<li><a href="#robust-q3-results-and-growth-outlook-for-samvardhana-motherson">Robust Q3 Results and Growth Outlook for Samvardhana Motherson</a></li>
<li><a href="#titan-q3fy26-strong-growth-driven-by-lightweight-jewellery-amid-rising-gold-prices">Titan Q3FY26 Strong Growth Driven by Light‑Weight Jewellery Amid Rising Gold Prices</a></li>
<li><a href="#apollo-hospitals-q3-fy26-earnings-call-highlights">Apollo Hospitals Q3 FY26 Earnings Call Highlights</a></li>
<li><a href="#gravita-indias-strategic-acquisition-of-rashtriya-metal-industries">Gravita India’s Strategic Acquisition of Rashtriya Metal Industries</a></li>
<li><a href="#us-policy-impact-on-indian-pharma-observations-earnings-trends-and-outlook">US Policy Impact on Indian Pharma: Observations, Earnings Trends, and Outlook</a></li>
<li><a href="#severe-floods-displace-over-50000-colombian-families-cnbc-promotes-indias-largest-startup-platform">Severe Floods Displace Over 50,000 Colombian Families; CNBC Promotes India’s Largest Startup Platform</a></li>
<li><a href="#steady-global-silver-demand-forecast-for-2026-amid-mixed-market-signals">Steady Global Silver Demand Forecast for 2026 Amid Mixed Market Signals</a></li>
<li><a href="#jubilant-foodworks-q3fy26-highlights">Jubilant Foodworks Q3FY26 Highlights</a></li>
<li><a href="#balrampur-chini-mills-q3-performance-and-future-outlook">Balrampur Chini Mills Q3 Performance and Future Outlook</a></li>
<li><a href="#young-turks-at-22-celebrating-indias-biggest-startup-platform">Young Turks at 22: Celebrating India’s Biggest Startup Platform</a></li>
<li><a href="#market-open-highlights-nifty-near-26000-gains-in-consumer-auto-stocks-mixed-breadth">Market Open Highlights: Nifty Near 26,000, Gains in Consumer &amp; Auto Stocks, Mixed Breadth</a></li>
<li><a href="#m-s-a-i-index-updates-inclusions-exclusions-and-weight-stability">M S A I Index Updates – Inclusions, Exclusions, and Weight Stability</a></li>
<li><a href="#eicher-motors-q3-fy26-earnings-surge-tata-motors-secures-70000vehicle-order-from-indonesian-government">Eicher Motors Q3 FY26 Earnings Surge; Tata Motors Secures 70,000‑Vehicle Order from Indonesian Government</a></li>
<li><a href="#andrits-agns-indian-hydropump-storage-strategy-growth-projects-and-ai-integration">Andrits AGN’s Indian Hydro‑Pump Storage Strategy: Growth, Projects, and AI Integration</a></li>
<li><a href="#why-auto-makers-are-ramping-up-capacity">Why Auto Makers Are Ramping Up Capacity</a></li>
<li><a href="#what-are-the-key-stocks-sectors-in-focus-today-market-cues-with-rahul-arora-of-ashika-instl-eq">What Are The Key Stocks &amp; Sectors In Focus Today? | Market Cues With Rahul Arora Of Ashika Instl Eq</a></li>
<li><a href="#apollo-hospitals-q3-earnings-margin-expansion-digital-losses-narrow-positive-broker-outlook">Apollo Hospitals Q3 Earnings: Margin Expansion, Digital Losses Narrow, Positive Broker Outlook</a></li>
<li><a href="#aidriven-market-risks-prompt-cautious-global-equity-rotation">AI‑Driven Market Risks Prompt Cautious Global Equity Rotation</a></li>
<li><a href="#young-turks-at-22-cnbc-tv18s-longrunning-startup-showcase">Young Turks at 22: CNBC TV18’s Long‑Running Startup Showcase</a></li>
<li><a href="#market-outlook-mixed-us-equity-moves-indian-index-stability-earnings-focus-and-shortcovering-dynamics">Market Outlook: Mixed US Equity Moves, Indian Index Stability, Earnings Focus, and Short‑Covering Dynamics</a></li>
<li><a href="#asian-markets-mixed-as-us-retail-data-dampens-sentiment-earnings-spotlight-and-commodity-outlook">Asian Markets Mixed as US Retail Data Dampens Sentiment, Earnings Spotlight, and Commodity Outlook</a></li>
<li><a href="#mm-q3fy26-earnings-outlook">M&amp;M Q3FY26 Earnings Outlook</a></li>
<li><a href="#titan-q3-earnings-jewellery-drives-growth-amid-margins-miss">Titan Q3 Earnings: Jewellery Drives Growth Amid Margins Miss</a></li>
<li><a href="#indian-markets-poised-for-higher-open-amid-mixed-global-cues">Indian Markets Poised for Higher Open Amid Mixed Global Cues</a></li>
</ul>
</div>

<div id="apollo-hospitals-md-predicts-longterm-boom-in-indian-healthcare" class="section level2">
<h2>Apollo Hospitals MD Predicts Long‑Term Boom in Indian Healthcare</h2>
<p><a href="https://stockviz.github.io/reports02/eq-in/risk/in.APOLLOHOSP.html">APOLLOHOSP</a></p>
<p>Suneeta Reddy highlights strong structural demand, rising affordability and supportive GST reforms as drivers of growth. With only 70,000 hospital beds now available, the sector must expand tenfold to meet needs. Tier‑2 cities—contributing 35% of GDP—offer attractive returns on capital, suggesting the healthcare industry will remain a high‑growth, lucrative space for the next two decades</p>
<p><em>NDTV: <a href="https://youtu.be/s3ldhrVmA7k" class="uri">https://youtu.be/s3ldhrVmA7k</a> 12:45 (80s) </em></p>
</div>
<div id="healthcare-sector-outlook-growth-drivers-strategic-plans-and-impact-of-indiauseu-ftas" class="section level2">
<h2>Healthcare Sector Outlook: Growth Drivers, Strategic Plans, and Impact of India‑US/EU FTAs</h2>
<p><a href="https://stockviz.github.io/reports02/eq-in/risk/in.MEDANTA.html">MEDANTA</a></p>
<p>The interview highlights a robust 17% consolidated growth, with revenue reaching ₹6,477 crore and profit up 35% to ₹500 crore. Expansion plans focus on increasing bed capacity (adding 3‑4% revenue), scaling the diagnostic network (currently 2,457 centres generating ₹177 crore) to boost margins from 10.8% to ~25%, and leveraging the Polo Health pharmacy chain (7,000+ stores, 38,000 daily transactions) to cross‑sell services like online consultations, diagnostics, and insurance. Revenue growth is driven by both volume (+5%) and higher‑value cases (complex surgeries, robotics, transplants), with specialty gains in cardiology (+20%), oncology (+18%), and gastroenterology (+17%). A preventive healthcare push aims for ₹2,000 crore in revenue and 18,000 patients, targeting elderly, millennials with NCDs, and Gen Z. The company anticipates modest ARPB uplift from new hospitals, with margins normalizing in ~24 months, sustaining 17‑18% hospital revenue growth. The recent India‑US and EU FTAs, along with the budget’s medical tourism hubs, are expected to enhance clinical capabilities, attract foreign patients, and improve access to advanced equipment. Management is confident that, given limited bed capacity (≈70,000) and rising affordability, the healthcare sector can maintain double‑digit growth for the next two decades</p>
<p><em>NDTV: <a href="https://youtu.be/s-eDosxQgLw" class="uri">https://youtu.be/s-eDosxQgLw</a> 12:10 (596s) </em></p>
</div>
<div id="eu-us-trade-deals-government-consumption-push-boost-fii-prospects-nuvamas-shiv-deewan-highlights-opportunities-and-risks-at-nuvama-india-conference" class="section level2">
<h2>EU &amp; US Trade Deals, Government Consumption Push Boost FII Prospects, Nuvama’s Shiv Deewan Highlights Opportunities and Risks at Nuvama India Conference</h2>
<p><a href="https://stockviz.github.io/reports02/eq-in/risk/in.LTF.html">LTF</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.REGAAL.html">REGAAL</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.SBILIFE.html">SBILIFE</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.TITAN.html">TITAN</a></p>
<p>Shiv Deewan, MD of Nuvama Institutional Equities, noted a cautiously optimistic mood at the conference, with domestic investors still strong and foreign inflows beginning to return after months of outflows. He sees earnings recovery in large caps (e.g., Titan, L&amp;T, SBI) leading the market, with mid‑ and small‑caps expected to follow as earnings catch up. Key sectors attracting FII interest include banks, autos, chemicals, healthcare, and pharma, while tech/IT faces valuation concerns and a shift from services to solution‑oriented models amid AI disruptions. Valuation premiums (30‑50% over peers) remain a risk, and the pace of earnings recovery and trade‑deal clarity will guide investor timing. The rally is likely to be stock‑specific rather than broad‑based, with large caps leading and mid‑caps joining later in the year</p>
<p><em>CNBC-TV18: <a href="https://youtu.be/_29ZBibGApk" class="uri">https://youtu.be/_29ZBibGApk</a> 12:07 (587s) </em></p>
</div>
<div id="market-recap-management-insights-auto-fmcg-metals-and-regulatory-outlook" class="section level2">
<h2>Market Recap &amp; Management Insights – Auto, FMCG, Metals, and Regulatory Outlook</h2>
<p><a href="https://stockviz.github.io/reports02/eq-in/risk/in.TATAMOTORS.html">TATAMOTORS</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.AHLEAST.html">AHLEAST</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.GRAVITA.html">GRAVITA</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.BRITANNIA.html">BRITANNIA</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.GANESHBE.html">GANESHBE</a> <code>KOVAI</code> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.EICHERMOT.html">EICHERMOT</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.HISARMETAL.html">HISARMETAL</a></p>
<p>The Sensex held flat while the Nifty hovered above 25,950, led by strong auto and consumer durables gains, with IT lagging. Top gainers included Aicha Motors (robust Q3 earnings), Tata Motors (CV order from Indonesia), Polar Hospital (stellar Q3 across segments, 5% rally), and Britannia (margin expansion, target ₹7,000). BHAL fell due to an 8% discounted OFS. The segment wrap‑up featured management interviews: Gravita India’s Yogesh Malhotra discussed its upcoming copper acquisition (target closing 31 Mar, funded via internal accruals and QIP proceeds, aiming for 70% capacity utilisation, high‑single‑digit margins, and 25% ROI post‑synergy). Ganesh Ikar Spheer’s Yash Sharma outlined Q3 turnaround, regulatory challenges around recycled content mandates, and expectations of improved utilisation and EBITDA from FY27 onward, with long‑term brand agreements pending final government notification. The show concluded with a brief market wrap‑up noting green Nifty, pressure on mid‑caps, and stable banking sector performance</p>
<p><em>CNBC-TV18: <a href="https://youtu.be/0-buLvDJ75g" class="uri">https://youtu.be/0-buLvDJ75g</a> 11:59 (1222s) </em></p>
</div>
<div id="ganesha-ecospheres-outlook-regulatory-hurdles-capacity-utilization-and-fy27-growth-prospects" class="section level2">
<h2>Ganesha Ecosphere’s Outlook: Regulatory Hurdles, Capacity Utilization, and FY27 Growth Prospects</h2>
<p><a href="https://stockviz.github.io/reports02/eq-in/risk/in.GANECOS.html">GANECOS</a></p>
<p>In a CNBC TV18 interview, Director Yash Sharma discussed Ganesha Ecosphere’s recent performance and future outlook. The company faced a muted Q3 due to regulatory uncertainty surrounding a draft notification that allowed a three‑year carry‑forward of recycled‑content shortfalls, prompting brands to postpone recycled‑material usage. Although the draft has not yet become a final rule, the underlying mandate for 40 % recycled content in rigid applications remains in force, with a definitive 40 % brand‑level requirement expected from FY27.</p>
<p>Sharma reported that legacy operations are running at over 100 % capacity, while the new food‑grade recycled polymer (RPD) business is at 50‑55 % utilization, projected to rise to about 70 % soon and to 85‑90 % by FY27 as capacity gaps are resolved. The company is negotiating long‑term supply agreements with global and Indian brands, awaiting the final notification to lock in volumes.</p>
<p>Financially, EBITDA improved to ₹30.73 crore in Q3, up from earlier guidance of ₹20‑25 crore, and Sharma expects further gains in Q4 as utilization improves. Shareholders recently exercised warrants at ₹1,035 per share, and Sharma emphasized that the firm has built significant capacity and brand strength, positioning it to capture the upcoming market demand once the regulatory environment stabilizes</p>
<p><em>CNBC-TV18: <a href="https://youtu.be/KuL_AlZaP9k" class="uri">https://youtu.be/KuL_AlZaP9k</a> 11:54 (491s) </em></p>
</div>
<div id="britannia-q3-earnings-highlight-revenue-and-margin-growth" class="section level2">
<h2>Britannia Q3 Earnings Highlight Revenue and Margin Growth</h2>
<p><a href="https://stockviz.github.io/reports02/eq-in/risk/in.BRITANNIA.html">BRITANNIA</a></p>
<p>Britannia reported Q3 revenue up 8% and gross margin expanding 450 bps, with EBITDA margin improving 130 bps. After a GST‑related disruption in October, sales recovered in November‑December, driven by strong biscuit and adjacent‑category performance. A stable commodity environment helped sustain margins, and the stock rose over 3% on the news</p>
<p><em>CNBC-TV18: <a href="https://youtu.be/fE1oMCjmUIM" class="uri">https://youtu.be/fE1oMCjmUIM</a> 11:43 (60s) </em></p>
</div>
<div id="indiqube-spaces-outlook-strong-q3-performance-and-aggressive-expansion-in-indias-micromarkets" class="section level2">
<h2>IndiQube Spaces Outlook: Strong Q3 Performance and Aggressive Expansion in India’s Micro‑Markets</h2>
<p><a href="https://stockviz.github.io/reports02/eq-in/risk/in.INDIQUBE.html">INDIQUBE</a></p>
<p>IndiQube Spaces reported a Q3 revenue surge and a 32% rise in EBITDA, with occupancy reaching 84% across its portfolio. The company manages roughly 10 million sq ft, of which 6.3‑6.5 million sq ft is occupied and has an AUM of 9.5 million sq ft, leaving about 3.2 million sq ft of headroom. Rishi Das highlighted a focus on ~50 high‑performing micro‑markets (85‑95% occupancy) and a strategy of selecting locations near metros, opting for full‑building acquisitions, and delivering high‑quality services to sustain retention. Steady‑state centers (&gt;12 months) show 90‑91% occupancy, while newer centers (&lt;12 months) are at 81‑82%. Break‑even is typically reached within 5‑6 months of lease commencement, and 90%+ occupancy is achieved within a year. With ₹650 crore raised last year, the firm is using funds to repay debt and finance fit‑out expansion, focusing on tier‑1 cities (Bangalore, Mumbai, NCR, Hyderabad) and continuing tier‑2 city additions. AUM is expected to grow by 1.5‑2 million sq ft annually, with a 12‑18 month pipeline lag, aiming for ~30‑50% revenue growth in FY27</p>
<p><em>CNBC-TV18: <a href="https://youtu.be/772kjTfUxzs" class="uri">https://youtu.be/772kjTfUxzs</a> 11:37 (459s) </em></p>
</div>
<div id="robust-q3-results-and-growth-outlook-for-samvardhana-motherson" class="section level2">
<h2>Robust Q3 Results and Growth Outlook for Samvardhana Motherson</h2>
<p><a href="https://stockviz.github.io/reports02/eq-in/risk/in.MOTHERSON.html">MOTHERSON</a></p>
<p>Samvardhana Motherson reported record Q3 revenue and margins above 9.5%, driven by strong performance in modules &amp; polymer (9.7% margin) and integrated assemblies (15.2% margin). Management highlighted structural margin improvements, pass‑through of higher copper prices, and robust growth in emerging non‑auto segments—consumer electronics and aerospace—now contributing about 5% of revenue with plans to expand. Acquisitions and new capacity (including a large plant) are expected to boost revenue to over $2 bn from new businesses and increase CAPEX to ~₹6,000 cr in FY26. North American commercial‑vehicle volumes are rebounding after a sharp dip, and the company remains optimistic about sustained growth across its diversified portfolio</p>
<p><em>CNBC-TV18: <a href="https://youtu.be/xuocdHLcDeM" class="uri">https://youtu.be/xuocdHLcDeM</a> 11:35 (642s) </em></p>
</div>
<div id="titan-q3fy26-strong-growth-driven-by-lightweight-jewellery-amid-rising-gold-prices" class="section level2">
<h2>Titan Q3FY26 Strong Growth Driven by Light‑Weight Jewellery Amid Rising Gold Prices</h2>
<p><a href="https://stockviz.github.io/reports02/eq-in/risk/in.TBZ.html">TBZ</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.TITAN.html">TITAN</a></p>
<p>Titan reported a 40% YoY revenue jump and a 100‑basis‑point margin expansion in Q3FY26, driven largely by a shift to lightweight, lower‑carat jewellery to offset soaring gold prices. Buyer growth remained flat, with studded‑jewellery’s share falling to ~26% as gold‑price‑driven price hikes compress volumes. The company is piloting lab‑grown diamond offerings, opening a few “Beyond” stores and planning 8‑10 more in the next 4‑5 months, though sales figures are still premature. Internationally, Titan completed a 67% stake in Damas (GCC) and is expanding Tanishq’s presence there, while also opening stores in the US and planning entry into Canada in FY27. EBIT is guided at ~11‑11.5%, with potential downside if gold prices rise further. No current plans to acquire TBZ</p>
<p><em>CNBC-TV18: <a href="https://youtu.be/K5RrSBiH_Zg" class="uri">https://youtu.be/K5RrSBiH_Zg</a> 11:23 (507s) </em></p>
</div>
<div id="apollo-hospitals-q3-fy26-earnings-call-highlights" class="section level2">
<h2>Apollo Hospitals Q3 FY26 Earnings Call Highlights</h2>
<p><a href="https://stockviz.github.io/reports02/eq-in/risk/in.APOLLOHOSP.html">APOLLOHOSP</a></p>
<p>Apollo Hospitals posted a strong Q3 FY26, with profits tripling YoY and margins expanding. Average revenue per patient (ARPP) rose 11% to ₹1.8 lakh, driven by a higher share of high‑margin procedures and an 8% volume boost from increased insurance tie‑ups, now accounting for about 48% of total patients (up from 43%). Occupancy is expected to reach ~70% within the next two quarters. Digital health saw GMV grow 38% (525% YoY) and daily active users rise 18% to 9.2 lakh, though revenue growth softened; cash losses in the segment are at a record low, with breakeven anticipated next quarter. The Apollo HealthCo demerger has received CIC approval and the listing timeline (Q4 FY27/Q1 FY28) remains on track. The hospital network is adding 1,325 beds in the next six months and another 1,500 in FY28‑29, targeting ~18% revenue growth. Promoters intend to retain full ownership, and discussions with the Delhi government on the Indraprastha Hospital stake are ongoing but not yet finalized. Five percent of the hospital’s stock is performing exceptionally well</p>
<p><em>CNBC-TV18: <a href="https://youtu.be/hnwmKNyMiRc" class="uri">https://youtu.be/hnwmKNyMiRc</a> 11:16 (572s) </em></p>
</div>
<div id="gravita-indias-strategic-acquisition-of-rashtriya-metal-industries" class="section level2">
<h2>Gravita India’s Strategic Acquisition of Rashtriya Metal Industries</h2>
<p><a href="https://stockviz.github.io/reports02/eq-in/risk/in.GRAVITA.html">GRAVITA</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.HISARMETAL.html">HISARMETAL</a></p>
<p>Gravita India’s CEO Yogesh Malhotra confirmed the Rs 565 cr purchase of Rashtriya Metal Industries, targeting closure by 31 March. Funding will come from internal accruals and surplus QIP proceeds, without fresh debt. The deal is part of a broader expansion plan to raise capacity to ~7 lakh tons by FY 29, requiring ₹1,200‑1,300 cr for capacity projects and an additional ₹1,000 cr working capital. RMIL contributes ~₹900 cr revenue and ₹60 cr EBIT (≈14% ROIC), with scope to boost utilization from 50% to 65‑70% and expand capacity to 50,000 t/yr, potentially lifting FY 27 revenue contribution to ~₹1,200 cr at high‑single‑digit margins. Synergies include better scrap utilization and marketing overlap, aiming to raise RMIL’s ROIC toward the group’s 25% target. Gravita’s lead business will grow 20‑25% in volume, maintaining EBITDA of ₹90‑120 per kg, and the company aspires to achieve ₹1,000 cr EBITDA by FY 29‑30 through organic growth, brownfield/greenfield projects and selective acquisitions</p>
<p><em>CNBC-TV18: <a href="https://youtu.be/FJ4eeoBMHek" class="uri">https://youtu.be/FJ4eeoBMHek</a> 11:14 (528s) </em></p>
</div>
<div id="us-policy-impact-on-indian-pharma-observations-earnings-trends-and-outlook" class="section level2">
<h2>US Policy Impact on Indian Pharma: Observations, Earnings Trends, and Outlook</h2>
<p><a href="https://stockviz.github.io/reports02/eq-in/risk/in.SPARC.html">SPARC</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.AJANTPHARM.html">AJANTPHARM</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.DRREDDY.html">DRREDDY</a></p>
<p>The discussion highlighted recent FDA 483 observations at the company’s Unit 3 and Unit 7 facilities, noting such inspections are routine for U.S. exporters and unlikely to cause major disruption given the firm’s strong compliance history. In the Q3 earnings season, domestic‑focused Indian pharma firms—Sun Pharma, Ajanta Pharma, Dr Reddy’s and Zyda—showed solid growth, with Sun Pharma posting a 16% worldwide increase, while performance in the U.S. generic market was mixed: some firms beat expectations, others missed, and the broader outlook points to a downturn for U.S. generics. This is compounded by the lingering Section 232 trade investigation, which creates uncertainty over preferential treatment for Indian generics. Analysts expect U.S. manufacturers to gradually diversify away from heavy reliance on Indian (and Chinese) supply, but tariffs are unlikely to be an effective remedy. Overall, while the U.S. segment faces headwinds, growth in domestic and other international markets remains the primary driver for Indian pharma companies</p>
<p><em>CNBC-TV18: <a href="https://youtu.be/q_yFt9OQdh8" class="uri">https://youtu.be/q_yFt9OQdh8</a> 11:04 (281s) </em></p>
</div>
<div id="severe-floods-displace-over-50000-colombian-families-cnbc-promotes-indias-largest-startup-platform" class="section level2">
<h2>Severe Floods Displace Over 50,000 Colombian Families; CNBC Promotes India’s Largest Startup Platform</h2>
<p><a href="https://stockviz.github.io/reports02/eq-in/risk/in.TVVISION.html">TVVISION</a></p>
<p>Heavy rains in Colombia have caused catastrophic flooding, forcing more than 50,000 families to evacuate their homes. The broadcast then shifts to a promotional segment for India’s biggest startup platform, highlighting its two‑decade journey and its feature on CNBC TV 18, inviting viewers to follow the show and its social media channels</p>
<p><em>CNBC-TV18: <a href="https://youtu.be/6dUp9sUyzAY" class="uri">https://youtu.be/6dUp9sUyzAY</a> 10:55 (194s) </em></p>
</div>
<div id="steady-global-silver-demand-forecast-for-2026-amid-mixed-market-signals" class="section level2">
<h2>Steady Global Silver Demand Forecast for 2026 Amid Mixed Market Signals</h2>
<p><a href="https://stockviz.github.io/reports02/eq-in/risk/in.SILVERTUC.html">SILVERTUC</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.BANKBARODA.html">BANKBARODA</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.AXISBANK.html">AXISBANK</a></p>
<p>Silver’s volatility has eased, with prices hovering around $80‑$85 per ounce after a recent high of $121. Investment demand—driven by ETFs, retail, institutional and central‑bank buying—is robust, offset by declines in industrial (‑2%), jewelry (‑9%) and silverware (‑17%) demand. The global deficit shrinks from 117 million ounces (2023) to 67 million ounces (2024) and is expected to stay modest through 2026. Supply will rise, with total output up 1.5% and mine production up 1%—the strongest growth in 4‑5 years—while recycling adds another 7%. Analysts project silver prices between $85‑$100 this year, with targets ranging from $50 to $110 for the near term</p>
<p><em>CNBC-TV18: <a href="https://youtu.be/AKGsfHo_BWY" class="uri">https://youtu.be/AKGsfHo_BWY</a> 10:24 (181s) </em></p>
</div>
<div id="jubilant-foodworks-q3fy26-highlights" class="section level2">
<h2>Jubilant Foodworks Q3FY26 Highlights</h2>
<p><a href="https://stockviz.github.io/reports02/eq-in/risk/in.CANHLIFE.html">CANHLIFE</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.JUBLFOOD.html">JUBLFOOD</a></p>
<p>Revenue rose 11.8% to ₹1,801 cr, margins expanded over 100 bps, and profit jumped ~32%. Domino’s same‑store sales grew ~5% for an eighth straight quarter, while Popeyes posted double‑digit same‑store growth. Analysts maintain buy calls: Jeffries TP ₹850, CLSA TP ₹505, HSBC TP ₹700. Management projects 5‑7% like‑for‑like growth in the coming quarters</p>
<p><em>CNBC-TV18: <a href="https://youtu.be/r4SYl9SFQoc" class="uri">https://youtu.be/r4SYl9SFQoc</a> 10:22 (69s) </em></p>
</div>
<div id="balrampur-chini-mills-q3-performance-and-future-outlook" class="section level2">
<h2>Balrampur Chini Mills Q3 Performance and Future Outlook</h2>
<p><a href="https://stockviz.github.io/reports02/eq-in/risk/in.BALRAMCHIN.html">BALRAMCHIN</a></p>
<p>Balrampur Chini Mills posted robust Q3 numbers driven by higher volumes and better realizations in its sugar and distillery divisions. CFO Pramod Patwari noted that actual sugar output is expected around 28.8 Mt (net of ethanol diversion), slightly dipping into opening stocks, with current farm‑gate prices at ₹41‑41.5 /kg and no further price surge anticipated. SAP is up ₹30 per quintal, yielding a 5‑6 % gain that should improve overhead absorption and modestly boost recovery margins. Ethanol procurement prices remain flat, pressuring distillery margins, but the company plans to continue juice‑heavy and B‑heavy ethanol production pending price revisions. The firm aims to commercialize PLA in Q3 FY27, targeting full‑capacity utilization and ~₹2,000 cr revenue by FY28, supported by a sizable institutional customer base (≈65 % of sales) and emerging market opportunities such as sachet packaging for pan‑masala. Despite rising health consciousness and GLP‑1 drug trends, institutional demand is expected to grow at a 1‑1.5 % CAGR</p>
<p><em>CNBC-TV18: <a href="https://youtu.be/5JU14wnDcuk" class="uri">https://youtu.be/5JU14wnDcuk</a> 10:12 (486s) </em></p>
</div>
<div id="young-turks-at-22-celebrating-indias-biggest-startup-platform" class="section level2">
<h2>Young Turks at 22: Celebrating India’s Biggest Startup Platform</h2>
<p><a href="https://stockviz.github.io/reports02/eq-in/risk/in.TVVISION.html">TVVISION</a></p>
<p>The segment highlights how building India’s largest startup platform required a two‑decade journey from obscurity to prominence, chronicling the nation’s most influential entrepreneurs. It underscores the show’s role in documenting the startup ecosystem and marks its status as the longest‑running entrepreneurship series, now in its 22nd season on CNBC TV 18</p>
<p><em>CNBC-TV18: <a href="https://youtu.be/dNA8Lnad3Vc" class="uri">https://youtu.be/dNA8Lnad3Vc</a> 09:54 (186s) </em></p>
</div>
<div id="market-open-highlights-nifty-near-26000-gains-in-consumer-auto-stocks-mixed-breadth" class="section level2">
<h2>Market Open Highlights: Nifty Near 26,000, Gains in Consumer &amp; Auto Stocks, Mixed Breadth</h2>
<p><a href="https://stockviz.github.io/reports02/eq-in/risk/in.APOLLOHOSP.html">APOLLOHOSP</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.BRITANNIA.html">BRITANNIA</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.WAKEFIT.html">WAKEFIT</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.HDFCBANK.html">HDFCBANK</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.NESTLEIND.html">NESTLEIND</a> <code>ANSALHSG</code> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.KTKBANK.html">KTKBANK</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.ATL.html">ATL</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.SKIPPER.html">SKIPPER</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.SUNPHARMA.html">SUNPHARMA</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.MAXHEALTH.html">MAXHEALTH</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.TITAN.html">TITAN</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.LAXMIDENTL.html">LAXMIDENTL</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.MCX.html">MCX</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.HEG.html">HEG</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.TVSSCS.html">TVSSCS</a> <code>PIONDIST</code> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.HEROMOTOCO.html">HEROMOTOCO</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.ALLDIGI.html">ALLDIGI</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.IEX.html">IEX</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.AARON.html">AARON</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.ROHLTD.html">ROHLTD</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.HBLENGINE.html">HBLENGINE</a></p>
<p>The Sensex rose 108 points to 84,382 and the Nifty hovered around 25,970‑26,000, up about 0.15 %. Bank Nifty was flat, while mid‑cap and small‑cap indices were largely unchanged. More stocks were higher than lower (≈1,300 up vs 1,150 down). Earnings‑driven leaders included Hero Motors (+5% gap to a 52‑week high), Royal Enfield, Titan, Max Healthcare, Nestle, TVS Supply Chain, and HEG, with high‑volume gainers such as Aisha and Polomar. Declines featured HDFC Bank (down 1.25% on the day, ~6.5% YTD), distilleries, Karnataka Bank, MCX, Hero Motorcorp, Stir Light, Key Industries, and Skipper, many of which were profit‑taking. Market breadth is converging and volumes are thin on many stocks</p>
<p><em>CNBC-TV18: <a href="https://youtu.be/Q8al4AgFpKo" class="uri">https://youtu.be/Q8al4AgFpKo</a> 09:53 (317s) </em></p>
</div>
<div id="m-s-a-i-index-updates-inclusions-exclusions-and-weight-stability" class="section level2">
<h2>M S A I Index Updates – Inclusions, Exclusions, and Weight Stability</h2>
<p><a href="https://stockviz.github.io/reports02/eq-in/risk/in.5PAISA.html">5PAISA</a> <code>BURNPUR</code> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.AAATECH.html">AAATECH</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.CANHLIFE.html">CANHLIFE</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.IRCTC.html">IRCTC</a> <code>L&amp;TFH</code> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.ASHAPURMIN.html">ASHAPURMIN</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.ANUP.html">ANUP</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.AGIIL.html">AGIIL</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.KNRCON.html">KNRCON</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.ASHOKA.html">ASHOKA</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.ALLDIGI.html">ALLDIGI</a> <code>AEGISCHEM</code> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.PREMIERENE.html">PREMIERENE</a></p>
<p>M S A I announced changes effective Feb 27 2026: AB Capital and L&amp;T Finance Holdings will join the M S A I Standard Index, offsetting the removal of IRCTC, keeping India’s weight in the index steady at ~14.1% with expected inflows of $257 M and $238 M respectively and outflows of $142 M from IRCTC. The Small‑Cap Index will shrink to 480 stocks (down from 508), adding firms such as Premium Energies, NSTL, MQO, JSLU, Cement, Ashapura Mine, KANNA, HSBC Life, and Thiroquoi Technologies, while dropping names like Gokhaldas Expo, Stellite Tech, KNR, JKMAR, Infra, VRR Logistics, Ashoka Belkorn, and Anup Engineering. The adjustments largely match analyst expectations</p>
<p><em>CNBC-TV18: <a href="https://youtu.be/lfVgTKoDLfM" class="uri">https://youtu.be/lfVgTKoDLfM</a> 09:38 (97s) </em></p>
</div>
<div id="eicher-motors-q3-fy26-earnings-surge-tata-motors-secures-70000vehicle-order-from-indonesian-government" class="section level2">
<h2>Eicher Motors Q3 FY26 Earnings Surge; Tata Motors Secures 70,000‑Vehicle Order from Indonesian Government</h2>
<p><a href="https://stockviz.github.io/reports02/eq-in/risk/in.TATAMOTORS.html">TATAMOTORS</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.EICHERMOT.html">EICHERMOT</a></p>
<p>Eicher Motors jumped nearly 3% in pre‑opening trade after posting a strong Q3 FY26, with margins hitting a five‑quarter high of 25.5% and revenue up 23% on volume gains of 21% for Royal Enfield and 24% for commercial vehicles; EBITDA rose 30% and the company forecasts continued momentum into Q4 and FY27. Meanwhile, Tata Motors’ commercial‑vehicle arm landed a massive Indonesian government order for 70,000 units (35,000 Yodha pickups and 35,000 Alta T.7 trucks), valued at roughly ₹7‑9 billion, lifting its stock about 3% pre‑open</p>
<p><em>CNBC-TV18: <a href="https://youtu.be/aC2iMVyBczQ" class="uri">https://youtu.be/aC2iMVyBczQ</a> 09:37 (84s) </em></p>
</div>
<div id="andrits-agns-indian-hydropump-storage-strategy-growth-projects-and-ai-integration" class="section level2">
<h2>Andrits AGN’s Indian Hydro‑Pump Storage Strategy: Growth, Projects, and AI Integration</h2>
<p><a href="https://stockviz.github.io/reports02/eq-in/risk/in.TATAPOWER.html">TATAPOWER</a></p>
<p>Frederic Swaz detailed Andrits AGN’s three‑decade presence in India, highlighting dozens of hydro‑pump storage projects (10 large, many medium) with capacities spanning several years, and emphasizing the role of water‑based batteries and synchronous condensers in stabilizing a renewable‑heavy grid. He noted logistical challenges in rugged sites but strong port infrastructure, ongoing investment to expand capacity, and the use of AI and data analytics—partnered with Microsoft—to optimize plant operations and drive innovation. The company plans sustained long‑term investment across India, Asia, Europe, and the Americas over the next five years</p>
<p><em>CNBC-TV18: <a href="https://youtu.be/ghCFtWbYRuc" class="uri">https://youtu.be/ghCFtWbYRuc</a> 09:34 (500s) </em></p>
</div>
<div id="why-auto-makers-are-ramping-up-capacity" class="section level2">
<h2>Why Auto Makers Are Ramping Up Capacity</h2>
<p><a href="https://stockviz.github.io/reports02/eq-in/risk/in.ROHLTD.html">ROHLTD</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.AETHER.html">AETHER</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.HYUNDAI.html">HYUNDAI</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.MARUTI.html">MARUTI</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.EICHERMOT.html">EICHERMOT</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.PENINLAND.html">PENINLAND</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.MM.html">M&amp;M</a></p>
<p>Indian automakers—including iShow Motors, Mahindra &amp; Mahindra, Maruta Suzuki, Hyundai, and Jaguar Land Rover—are announcing massive CAPEX projects that boost production capacity by up to 66 %. The drivers are (1) a structural surge in domestic demand after the JST rate cut, pulling in sidelined buyers; (2) existing plants operating near 80 % utilization, prompting expansion to meet demand; (3) growing export opportunities, especially for firms like Maruti, aided by new FTAs; and (4) India’s rising global competence in automotive technology. These factors suggest a durable demand outlook and justify the aggressive capacity additions across the sector</p>
<p><em>NDTV: <a href="https://youtu.be/bJHiIs6cIyk" class="uri">https://youtu.be/bJHiIs6cIyk</a> 09:29 (203s) </em></p>
</div>
<div id="what-are-the-key-stocks-sectors-in-focus-today-market-cues-with-rahul-arora-of-ashika-instl-eq" class="section level2">
<h2>What Are The Key Stocks &amp; Sectors In Focus Today? | Market Cues With Rahul Arora Of Ashika Instl Eq</h2>
<p><a href="https://stockviz.github.io/reports02/eq-in/risk/in.UBL.html">UBL</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.BANG.html">BANG</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.ITC.html">ITC</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.BRITANNIA.html">BRITANNIA</a> <code>BURGERKING</code> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.TATACONSUM.html">TATACONSUM</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.TITAN.html">TITAN</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.JUBLFOOD.html">JUBLFOOD</a></p>
<p><strong>Title:</strong> Market Outlook &amp; Sector Picks: Liquidity Constraints, Consolidation Ahead, and Consumer Discretionary Opportunities</p>
<p><strong>Summary:</strong><br />
Rahul Arora of Ashika Institutional Equities explains that Indian market performance is being driven primarily by liquidity – both domestic and foreign. With foreign investors facing currency depreciation and modest earnings yields (12‑13% earnings versus 4‑5% net returns after inflation and taxes), and domestic investors seeing similar spreads versus safe assets, he argues that India must deliver 20% market returns—requiring 16‑18% earnings growth—to attract fresh capital. He sees the near‑term as a year of consolidation, with the Nifty likely ranging between 24,500‑27,500, while gold and silver remain viable hedges.</p>
<p>On the stock side, Arora recommends high‑growth consumer‑discretionary names that can outpace staple volume stagnation: Titan (double‑digit growth), United Breweries, hotel and aviation stocks, and other liquor brands. He cautions against overvalued consumer staples (Britannia, Tata Consumer, Nestle) and warns that QSRs such as Jubilant Foodworks, McDonald’s and other fast‑food chains face pricing pressure, low footfall, and valuation concerns, making them less attractive despite short‑term rally. Overall, the outlook is for modest returns, a need for stronger earnings growth, and a focus on select discretionary stocks while staying wary of traditional staples and QSRs.</p>
<p><em>CNBC-TV18: <a href="https://youtu.be/5EtrG2xrNuQ" class="uri">https://youtu.be/5EtrG2xrNuQ</a> 09:15 (443s) </em></p>
</div>
<div id="apollo-hospitals-q3-earnings-margin-expansion-digital-losses-narrow-positive-broker-outlook" class="section level2">
<h2>Apollo Hospitals Q3 Earnings: Margin Expansion, Digital Losses Narrow, Positive Broker Outlook</h2>
<p><a href="https://stockviz.github.io/reports02/eq-in/risk/in.APOLLOHOSP.html">APOLLOHOSP</a></p>
<p>Apollo Hospitals posted an inline but solid Q3 performance, with healthcare services revenue up ~14% and ABHA growth of 18%. Average revenue per patient rose 11% to ₹1.8 lac, while occupancy slipped slightly to 67% from 68% a year ago. Apollo Health &amp; Lifestyle saw a 20% revenue jump, with PAT climbing to ₹87 cr from ₹32 cr in FY25 Q3, driven by diagnostic growth. Digital losses narrowed quarter‑on‑quarter, contributing to margin expansion. Brokers maintain a target price of ₹9,600, noting the stock trades below its historical average and remains attractively valued. The upcoming 2 pm earnings call is expected to attract further analyst commentary</p>
<p><em>NDTV: <a href="https://youtu.be/fOvfdrb9eNU" class="uri">https://youtu.be/fOvfdrb9eNU</a> 09:07 (108s) </em></p>
</div>
<div id="aidriven-market-risks-prompt-cautious-global-equity-rotation" class="section level2">
<h2>AI‑Driven Market Risks Prompt Cautious Global Equity Rotation</h2>
<p><a href="https://stockviz.github.io/reports02/eq-in/risk/in.JMFINANCIL.html">JMFINANCIL</a></p>
<p>Citi’s Drew Pettit discussed the impact of AI disruptions on financial services and software valuations, noting a de‑risking of terminal multiples that is driving sell‑offs. He highlighted a balanced, “bar‑bell” approach—buying dips in software while maintaining cyclicals—and outlined Citi’s global equity stance: overweight emerging markets, neutral on the US, underweight UK and Australia, with a neutral but watchful view on India pending trade‑news and earnings revisions. He also pointed to increased U.S. investor appetite for international equities, diversified fixed‑income exposure, and the broader trend of global diversification amid heightened volatility in commodities and markets</p>
<p><em>CNBC-TV18: <a href="https://youtu.be/rSD71enxitE" class="uri">https://youtu.be/rSD71enxitE</a> 08:57 (361s) </em></p>
</div>
<div id="young-turks-at-22-cnbc-tv18s-longrunning-startup-showcase" class="section level2">
<h2>Young Turks at 22: CNBC TV18’s Long‑Running Startup Showcase</h2>
<p><a href="https://stockviz.github.io/reports02/eq-in/risk/in.TVVISION.html">TVVISION</a></p>
<p>The segment celebrates the evolution of India’s biggest startup platform, tracing its two‑decade journey from obscurity to a renowned brand that chronicles and honors the nation’s most influential entrepreneurs. It highlights the show’s status as the longest‑running program on startups, its presence on CNBC TV 18 and cnbcTV18.com, and invites viewers to follow for more news and updates</p>
<p><em>CNBC-TV18: <a href="https://youtu.be/5ylCHYMy69k" class="uri">https://youtu.be/5ylCHYMy69k</a> 08:55 (183s) </em></p>
</div>
<div id="market-outlook-mixed-us-equity-moves-indian-index-stability-earnings-focus-and-shortcovering-dynamics" class="section level2">
<h2>Market Outlook: Mixed US Equity Moves, Indian Index Stability, Earnings Focus, and Short‑Covering Dynamics</h2>
<p><a href="https://stockviz.github.io/reports02/eq-in/risk/in.ASHOKLEY.html">ASHOKLEY</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.MM.html">M&amp;M</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.STANLEY.html">STANLEY</a></p>
<p>US stocks ended slightly lower with the Nasdaq down 0.6%, driven by pressure on software, insurance brokers, and wealth‑management firms amid concerns over new AI specialist models. Weak December retail sales nudged the 10‑year Treasury yield to 4.14% and set expectations for possible rate cuts, though Fed hawks remain cautious. Oil prices stayed flat despite geopolitical tension over Iran. In India, the Nifty hovered around 26,052, showing limited momentum after a recent rally; weekly expiry and short‑covering by foreign institutions helped sustain levels, with FII net short positions falling sharply. Broad‑market breadth remains positive, with mid‑caps recovering and more stocks advancing than declining. The day ahead features heavy earnings (e.g., M&amp;M, Ashok Leyland) and the US jobs report, while key technical levels to watch are resistance near 26,100 and support around 25,700 for the Nifty, and 59,400–59,500 for Nifty Bank</p>
<p><em>CNBC-TV18: <a href="https://youtu.be/nrtfk2DlC14" class="uri">https://youtu.be/nrtfk2DlC14</a> 08:35 (521s) </em></p>
</div>
<div id="asian-markets-mixed-as-us-retail-data-dampens-sentiment-earnings-spotlight-and-commodity-outlook" class="section level2">
<h2>Asian Markets Mixed as US Retail Data Dampens Sentiment, Earnings Spotlight, and Commodity Outlook</h2>
<p><a href="https://stockviz.github.io/reports02/eq-in/risk/in.IRCTC.html">IRCTC</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.LTF.html">LTF</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.AETHER.html">AETHER</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.BHEL.html">BHEL</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.ABCAPITAL.html">ABCAPITAL</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.BRITANNIA.html">BRITANNIA</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.EICHERMOT.html">EICHERMOT</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.AUROPHARMA.html">AUROPHARMA</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.MUTHOOTFIN.html">MUTHOOTFIN</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.TITAN.html">TITAN</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.MM.html">M&amp;M</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.IEX.html">IEX</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.JUBLFOOD.html">JUBLFOOD</a></p>
<p>The Asian markets opened mixed, with most indices holding gains despite weak US retail sales and AI‑related concerns. US indices closed unevenly: the S&amp;P 500 fell, the Nasdaq slipped, while the Dow hit a record high. Key earnings highlighted include strong Q3 results from Isha Motors, Jubilant Foodworks, Titan, Britannia, and an anticipated robust report from Mahindra &amp; Mahindra. MSCI announced index changes effective Feb 27, and the government plans to offload up to 5% of BHEL via an OFS, targeting ₹4,500 crore. Futures data suggest the Nifty may open above 26,000, with put‑call ratios indicating bullish positioning. Commodity markets saw crude oil hover around $70/barrel amid US‑Iran tensions, while gold held support ahead of US inflation and jobs data; base metals faced pressure due to rising inventories and reduced Chinese demand. Upcoming catalysts include US non‑farm payrolls, inflation releases, and further earnings from M&amp;M and other sector leaders</p>
<p><em>CNBC-TV18: <a href="https://youtu.be/a0QS-esOWfI" class="uri">https://youtu.be/a0QS-esOWfI</a> 08:28 (1169s) </em></p>
</div>
<div id="mm-q3fy26-earnings-outlook" class="section level2">
<h2>M&amp;M Q3FY26 Earnings Outlook</h2>
<p><a href="https://stockviz.github.io/reports02/eq-in/risk/in.MM.html">M&amp;M</a></p>
<p>Mahindra &amp; Mahindra is expected to post robust Q3 FY26 results, driven by healthy volume growth in both auto and tractor segments. Revenue could rise ~27% YoY, profit up ~32%, and EBITDA expand ~28% with a core margin around 14.7%. Combined volumes are projected to increase 23% YoY, with auto volumes up 23% YoY (16% sequential) and tractor volumes up 23% YoY (22% sequential). Realizations may improve ~3.4% YoY but could slip 1% sequentially due to raw material cost pressures. Key focus areas include EV launches (e.g., XUV7), emission norm updates, and potential competition from US‑India trade dynamics. Internal metrics are also expected to be strong</p>
<p><em>CNBC-TV18: <a href="https://youtu.be/M22QvVPx2ZY" class="uri">https://youtu.be/M22QvVPx2ZY</a> 08:28 (135s) </em></p>
</div>
<div id="titan-q3-earnings-jewellery-drives-growth-amid-margins-miss" class="section level2">
<h2>Titan Q3 Earnings: Jewellery Drives Growth Amid Margins Miss</h2>
<p><a href="https://stockviz.github.io/reports02/eq-in/risk/in.STANLEY.html">STANLEY</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.KALYANKJIL.html">KALYANKJIL</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.TITAN.html">TITAN</a></p>
<p>Titan’s Q3 results showed an overall inline performance with notable highlights: jewellery revenue and net profit rose, propelled by festive collections and bundled offers, though margins fell short of expectations due to a weaker studded‑mix, high gold‑coin sales and increased marketing spend. Morgan Stanley kept an overweight rating with a ₹4,062 target, while CLS maintained an outperform stance at ₹4,369. The analog watches segment recorded a 19% YoY volume increase, and the IK domestic business grew 17% YoY. Brokers note the festive‑led demand boosted top‑line numbers, but margin pressure remains a concern</p>
<p><em>NDTV: <a href="https://youtu.be/a--xRu55Xdg" class="uri">https://youtu.be/a--xRu55Xdg</a> 08:20 (94s) </em></p>
</div>
<div id="indian-markets-poised-for-higher-open-amid-mixed-global-cues" class="section level2">
<h2>Indian Markets Poised for Higher Open Amid Mixed Global Cues</h2>
<p><a href="https://stockviz.github.io/reports02/eq-in/risk/in.APOLLOHOSP.html">APOLLOHOSP</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.ROHLTD.html">ROHLTD</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.AETHER.html">AETHER</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.BRITANNIA.html">BRITANNIA</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.EICHERMOT.html">EICHERMOT</a> <code>HALEOSLABS</code> <code>IOLCP</code> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.BAJFINANCE.html">BAJFINANCE</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.TITAN.html">TITAN</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.AUROPHARMA.html">AUROPHARMA</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.ASHOKLEY.html">ASHOKLEY</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.IEX.html">IEX</a> <a href="https://stockviz.github.io/reports02/eq-in/risk/in.JUBLFOOD.html">JUBLFOOD</a></p>
<p>The broadcast outlines a cautiously optimistic start for Indian equities, with Asian markets showing modest gains despite AI concerns and weak global data. Nifty’s implied open suggests a 70‑point rise, backed by strong FII buying and DII inflows, while key earnings from Isha Motors, Jubilant Foodworks, Titan, and Britannia have beaten expectations, supporting FMCG sentiment. Upcoming corporate actions include block deals in BHL and Aether Energy, and Iron Exchange’s new order. Market cues to watch are US non‑farm payrolls, AI‑related sentiment, and specific stocks like Muthoot Finance (ahead of earnings) and Aurobindo Pharma (plant concerns). Technical analysis points to Nifty holding above its 50‑day MA (25,790), with resistance at 26,000–26,130, and a bullish put‑call ratio indicating continued buying pressure</p>
<p><em>CNBC-TV18: <a href="https://youtu.be/anQP8EjSPEU" class="uri">https://youtu.be/anQP8EjSPEU</a> 07:48 (384s) </em></p>
</div>

&nbsp;
&nbsp;
<hr />
<p style="text-align: center;">Copyright &copy; 2023 SAS Data Analytics Pvt. Ltd. All rights reserved.</p>
<p style="text-align: center;"><a href="https://github.com/stockviz/reports/issues">&#x1F41E;</a></p>



</div>

<script>

// add bootstrap table styles to pandoc tables
function bootstrapStylePandocTables() {
  $('tr.odd').parent('tbody').parent('table').addClass('table table-condensed');
}
$(document).ready(function () {
  bootstrapStylePandocTables();
});


</script>

<!-- tabsets -->

<script>
$(document).ready(function () {
  window.buildTabsets("TOC");
});

$(document).ready(function () {
  $('.tabset-dropdown > .nav-tabs > li').click(function () {
    $(this).parent().toggleClass('nav-tabs-open');
  });
});
</script>

<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
